Mar 15, 2017 12:32 pm UTC| Business
JINHUA, China, March 15, 2017 -- Kandi Technologies Group, Inc. (the “Company” or “Kandi”) (Nasdaq:KNDI) today announced that it will report its full year 2016 onThursday, March 16, 2017, before stock markets open in...
School Specialty Announces Fiscal Year 2016 Fourth Quarter and Year-end Financial Results
Mar 15, 2017 12:31 pm UTC| Business
Q4 Revenues increased $9.6 million or 9.1% vs. 2015 Q4Q4 Net loss of $13.8 million, an improvement of $8.8 million vs. 2015 Q4FY 2016 Revenues increased $18.9 million or 3.0% vs. 2015FY Net Income of $14.8 million vs. a...
School Specialty Announces Fiscal Year 2016 Fourth Quarter and Year-end Financial Results
Mar 15, 2017 12:31 pm UTC| Business
Q4 Revenues increased $9.6 million or 9.1% vs. 2015 Q4Q4 Net loss of $13.8 million, an improvement of $8.8 million vs. 2015 Q4FY 2016 Revenues increased $18.9 million or 3.0% vs. 2015FY Net Income of $14.8 million vs. a...
TOP Ships Inc. Announces Filing of 2016 Annual Report on Form 20-F
Mar 15, 2017 12:30 pm UTC| Business
ATHENS, Greece, March 15, 2017 -- TOP Ships Inc. (Nasdaq:TOPS) (“Top Ships” or the “Company”), an international owner and operator of modern, fuel efficient “ECO” MR tanker vessels focusing on the transportation of...
Gulf Resources Announces Conference Call to Discuss Fourth Quarter & Fiscal Year 2016 Results
Mar 15, 2017 12:30 pm UTC| Business
SHOUGUANG, China, March 15, 2017 -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that...
Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
Mar 15, 2017 12:30 pm UTC| Business
OXNARD, Calif., March 15, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods...
Aptevo Therapeutics Announces New IXINITY Supply Available May 2017
Mar 15, 2017 12:30 pm UTC| Business
SEATTLE, March 15, 2017 -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced the successful manufactureof a recent bulk...
Venezuela Turmoil, India Tailwind: Why Stable $60–65 Oil Is Mildly Positive for Markets